September 28, 2021
This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
Dear Readers,
MRD testing during or after treatment is becoming increasingly important to inform how our CLL is treated. Learn more:
CLL Society’s Upcoming Webinar
Please register for the upcoming CLL Society Webinar, MRD: What Should It Mean to Me? featuring Dr. Anthony Mato discussing the growing role of MRD testing and research, as well as its evolving role in CLL management on Friday, August 14 at 12:30 PM ET / 11:30 AM CT / 10:30 AM MT / 9:30 AM PT. Learn more and register here.
Conference Coverage
This week, we are continuing our coverage of the 2020 Annual Meeting of the American Society of Clinical Oncology (ASCO), held virtually in May. Dr. Koffman takes us through numbers 6 and 5 of his “Top 12” CLL-relevant abstracts in short videos with accompanying text.
Dr. Koffman’s ASCO 2020 Top 12 Picks
- #6 Koffman presents a study investigating the cause of death in patients with newly diagnosed chronic lymphocytic leukemia.
- #5 Koffman presents a study of survival trends in CLL (chronic lymphocytic leukemia) and prognostic factors in the US: An analysis from the National Cancer Database (NCDB).
CLLAN COVID-19 Guidelines document
The CLL Society is an active member of CLLAN , the international CLL Advocates Network. Dr. Koffman was one of the lead writers creating this COVID-19 document, which serves as a signpost to reliable sources of information.
The CLL Society’s CLL-specific Support Groups
The big list of our ever-popular CLL-specific Support Groups can best be viewed on our Support Group calendar, so head on over to connect with the facilitator to register and attend the next (virtual!) meeting near you. You are invited!
Don’t Miss!
Our own Terry Evans is featured in Cancer Today.
Test Before Treat Survey
How much do you know about the critical tests which can predict which patients will do well on or fail certain medications? Prognostic testing should be done before each and every treatment decision; share your experience and test your knowledge by completing the Test Before Treat Survey!
Please Support the CLL Society, the only CLL-specific, physician-curated public charity dedicated to meeting the unmet needs of CLL patients and their caregivers which holds the GuideStar Platinum Seal of Transparency.
The CLL Society is invested in your long life.
Please invest in the long life of the CLL Society by investing in our work.
Thank you!
Stay safe.
We are all in this together.
Patty Koffman
Co-Founder & Communications Director
CLL Society
CLL Society Support Group Meetings Coming Up!
CLL Society Support Group meetings have moved to a virtual platform for most locations due to the threat of coronavirus. Support group members will receive an invitation to register for the meeting from the support group facilitator. If you are new to the group, please contact the RSVP email for the Support Group in your region. Once it is safe again, we will resume in-person meetings.
Visit the individual event listings on our website for the most up-to-date information on all CLL Society Support Group meetings.
Related posts
